All News

An abnormal protein found in the blood – called monoclonal gammopathy of undetermined significance (MGUS) – may lead to multiple myeloma progression, even after 30 years of disease stability, according to study results published in the New England Journal of Medicine.

Individual advocates and larger organizations offer hope as they help us understand what future treatments are in the pipeline.

The only person who can stop the fears and anxiety that cancer brings to your life is you. If you allow those thoughts to take over, you get in your own way of enjoying your life.

Tailored survivorship care plans (SCPs) may be beneficial for survivors of head and neck cancer, according to recent research.

After a cancer diagnosis and treatment, one may question when they will actually start to feel “normal” again, whatever that may be. The Ovarian Cancer Prognosis and Lifestyle (OPAL) study set out to help women with ovarian cancer to understand just that.

It's hard to stop comparing our sick bodies to the people around us, but once we do, as both patients and caretakers, we learn to honor our own experiences and value ourselves in new and beautiful ways.

When her sister had hit another roadblock in her treatment, Kim found something else – a remarkable young man who changed her perception of caregiving.

FDA approves first treatment approved for stage 3 unresectable non-small cell lung cancer to reduce the risk of the cancer progressing, when the cancer has not worsened after chemoradiation.

Gratitude helps get this cancer survivor through her cancer days, fears and worries.

Adolescent cancer survivors can improve fitness, cognition and quality of life through increased physical activity, according to study findings presented ahead of the American Society of Clinical Oncology’s (ASCO) Cancer Survivorship Symposium.

Sometimes scars from being attacked by a wolf would be much cooler.

Taking the extra time to have the more difficult conversations with your daughter about her breast health and breast cancer risk has the power to greatly improve and extend her own life.

Three years of scans every three months means finding a way to grow and change that's not limited or defined by cancer

Ivosidenib (AG-120) was granted a priority review designation by the Food and Drug Administration (FDA) for the treatment of patients with relapsed/refractory IDH1-mutant acute myeloid leukemia (AML), according to a statement from Agios Pharmaceuticals, the company developing the targeted therapy.

The availability of sexual aids and resources available to cancer survivors at a wide array of cancer centers appeared disappointingly low, according to survey results to be presented at the 2018 Cancer Survivorship Symposium.

Two-time cancer survivor shares the happiness of naptime and her alternatives too. Your body has been through lots and deserves a nap.

For the cancer patient, waiting seems an often too familiar state of being. In this article, one survivor shares her experience with periodic checkups and how they make her feel.

While adolescent and young adult survivors of cancer face an increased risk of long-term complications, many people in this group end up "lost to follow-up," according to recent research.

Should women who are not known to have a hereditary risk for ovarian cancer get screened? The US Preventive Services Task Force says no.

Learning to live with cancer may take a lifetime, but it is time well spent.

Roswell Park Cancer Center researchers shed light on disease incidence among women.

The Food and Drug Administration (FDA) approved Erleada (apalutamide) for the treatment of patients who have nonmetastatic castration-resistant prostate cancer (CRPC). The drug is now the first FDA-approved treatment in this setting.

Yes, I have a great admiration for the Olympic athletes who fall and get right back up. I know they have to wait another four years. But the cancer survivors I have met on my journey who fall and rebound are real heroes to me.

While obesity is a known risk factor for more than a dozen types of cancer – and poised to take over smoking as the leading preventable cause for the disease – it may actually play a beneficial role in men with metastatic melanoma, according to a recent study published in Lancet Oncology.

Researchers from Israel, the United Kingdom (UK) and Canada sought to determine the cost-effectiveness of Keytruda for the second-line treatment of patients with advanced bladder cancer. Drug costs were compared between the US, UK, Canada and Australia.

After a cancer diagnosis, are we more afraid of our fears of chemo or the chemo itself? This survivor walks through three common chemo fears and what her experiences were like with them.

This breast cancer and melanoma survivor sometimes likes to pretend and ponder about what life would have been if she hadn't gotten cancer.

This HPV-based test can help identify women who are at an increased risk for cervical cancer.